Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 94

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder: A Randomized Clinical Trial

Morin, Charles M., Edinger, Jack D., Beaulieu-Bonneau, Simon, Ivers, Hans, Krystal, Andrew D., Guay, Bernard, Bélanger, Lynda, Cartwright, Ann, Simmons, Bryan, Lamy, Manon, Busby, Mindy · 2020 · JAMA Psychiatry

Abstract

Importance: Despite evidence of efficacious psychological and pharmacologic therapies for insomnia, there is little information about what first-line treatment should be and how best to proceed when initial treatment fails. Objective: To evaluate the comparative efficacy of 4 treatment sequences involving psychological and medication therapies for insomnia and examine the moderating effect of psychiatric disorders on insomnia outcomes. Design, Setting, and Participants: In a sequential multiple-assignment randomized trial, patients were assigned to first-stage therapy involving either behavioral therapy (BT; n = 104) or zolpidem (zolpidem; n = 107), and patients who did not remit received a second treatment involving either medication (zolpidem or trazodone) or psychological therapy (BT or cognitive therapy [CT]). The study took place at Institut Universitaire en Santé Mentale de Québec, Université Laval, Québec City, Québec, Canada, and at National Jewish Health, Denver, Colorado, and enrollment of patients took place from August 2012 through July 2017. Main Outcomes and Measures: The primary end points were the treatment response and remission rates, defined by the Insomnia Severity Index total score. Results: Patients included 211 adults (132 women; mean [SD] age, 45.6 [14.9] years) with a chronic insomnia disorder, including 74 patients with a comorbid anxiety or mood disorder. First-stage therapy with BT or zolpidem produced equivalent weighted percentages of responders (BT, 45.5%; zolpidem, 49.7%; OR, 1.18; 95% CI, 0.60-2.33) and remitters (BT, 38.03%; zolpidem, 30.3%; OR, 1.41; 95% CI, 0.75-2.65). Second-stage therapy produced significant increases in responders for the 2 conditions, starting with BT (BT to zolpidem, 40.6% to 62.7%; OR, 2.46; 95% CI, 1.14-5.30; BT to CT, 50.1% to 68.2%; OR, 2.09; 95% CI, 1.01-4.35) but no significant change following zolpidem treatment. Significant increase in percentage of remitters was observed in 2 of 4 therapy sequences (BT to zolpidem, 38.1% to 55.9%; OR, 2.06; 95% CI, 1.04-4.11; zolpidem to trazodone, 31.4% to 49.4%; OR, 2.13; 95% CI, 0.91-5.00). Although response/remission rates were lower among patients with psychiatric comorbidity, treatment sequences that involved BT followed by CT or zolpidem followed by trazodone yielded better outcomes for patients with comorbid insomnia. Response and remission rates were well sustained through the 12-month follow-up. Conclusions and Relevance: Behavioral therapy and zolpidem medication produced equivalent response and remission rates. Adding a second treatment produced an added value for those whose insomnia failed to remit with initial therapies. Trial Registration: ClinicalTrials.gov Identifier: NCT01651442.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamapsychiatry.2020.1767

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 19

  1. Parthasarathy, 2015, Persistent insomnia is associated with mortality risk., Am J Med, 128, 268, 10.1016/j.amjmed.2014.10.015 · DOI · Paper page
  2. Sateia, 2017, Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline., J Clin Sleep Med, 13, 307, 10.5664/jcsm.6470 · DOI · Paper page
  3. Morin, 2009, Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial., JAMA, 301, 2005, 10.1001/jama.2009.682 · DOI · Paper page
  4. Morin, 2016, Sequential psychological and pharmacological therapies for comorbid and primary insomnia: study protocol for a randomized controlled trial., Trials, 17, 118, 10.1186/s13063-016-1242-3 · DOI
  5. Morin, 2011, The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response., Sleep, 34, 601, 10.1093/sleep/34.5.601 · DOI · Paper page
  6. Harvey, 2007, An open trial of cognitive therapy for chronic insomnia., Behav Res Ther, 45, 2491, 10.1016/j.brat.2007.04.007 · DOI · Paper page
  7. Harvey, 2008, Insomnia, psychiatric disorders, and the transdiagnostic perspective., Curr Dir Psychol Sci, 17, 299, 10.1111/j.1467-8721.2008.00594.x · DOI · Paper page
  8. Cascade, 2007, Current status of hypnotic prescribing habits in the United States., Psychiatry (Edgmont), 4, 24
  9. Wilt, 2016, Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the american college of physicians., Ann Intern Med, 165, 103, 10.7326/M15-1781 · DOI · Paper page
  10. Walsh, 2004, Drugs used to treat insomnia in 2002: regulatory-based rather than evidence-based medicine., Sleep, 27, 1441, 10.1093/sleep/27.8.1441 · DOI
  11. Krystal, 2009, A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice., Sleep Med Rev, 13, 265, 10.1016/j.smrv.2008.08.001 · DOI · Paper page
  12. Walsh, 1998, Subjective hypnotic efficacy of trazodone and zolpidem in DSM-III-R primary insomnia., Hum Psychopharmacol, 13, 191, 10.1002/(ISSN)1099-1077 · DOI
  13. Robins, 1995, Analysis of semiparametric regression models for repeated outcomes in the presence of missing data., J Am Stat Assoc, 90, 106, 10.1080/01621459.1995.10476493 · DOI · Paper page
  14. Dahmen, 2004, Sample size calculations for controlled clinical trials using generalized estimating equations (GEE)., Methods Inf Med, 43, 451, 10.1055/s-0038-1633896 · DOI
  15. Harvey, 2017, Mediators and treatment matching in behavior therapy, cognitive therapy and cognitive behavior therapy for chronic insomnia., J Consult Clin Psychol, 85, 975, 10.1037/ccp0000244 · DOI
  16. American Psychiatric Association, 2013, Diagnostic and Statistical Manual of Mental Disorders, 10.1176/appi.books.9780890425596 · DOI · Paper page
  17. Bootzin, 1991, Case Studies in Insomnia, 19, 10.1007/978-1-4757-9586-8_2 · DOI · Paper page
  18. Morin, 2003, Insomnia: A Clinical Guide to Assessment and Treatment
  19. European Medicines Agency (EMA), 2015, Guideline on Adjustment for Baseline Covariates in Clinical Trials (No. EMA/CHMP/295050/2013)

Cited by

See all 94

Metadata

Authors
Morin, C. M., Edinger, J. D., Beaulieu-Bonneau, S., Ivers, H., Krystal, A. D., Guay, B., Bélanger, L., Cartwright, A., Simmons, B., Lamy, M., & Busby, M.
Affiliations
  • École de psychologie, Université Laval, Québec City, Québec, Canada
  • National Jewish Health, Denver, Colorado
  • University of California, San Francisco
  • University of Colorado, Denver
Venue
JAMA Psychiatry
Published
2020-11-01
Volume
77
Issue
11
Pages
1107
ISSN
2168-622X
Cited by
94
References
23
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.